Literature DB >> 23101279

Epigenetic aspects in schizophrenia etiology and pathogenesis.

Nikolay T Popov1, Vili K Stoyanova, Nadezhda P Madzhirova, Tihomir I Vachev.   

Abstract

Epidemiological evidence suggests that etiology of schizophrenia may involve both the influence of genetic factors specific for the individual and the impact of the environment. It is quite likely that a crucial role in the disease development is played by molecular mechanisms mediating the interaction between genes and environment. Modern research have shown that epigenetic mechanisms or chemical modifications of deoxyribonucleic acids (DNA) and histone proteins remain unstable throughout life and can be changed by environmental factors. Thus the epigenetic mechanisms outline an attractive molecular hypothesis of the environment modelling role and the environmental contribution to schizophrenia progression. We give in the present study a general outline of schizophrenia as a pathological entity and discuss the role and involvement of environment versus genetic determinant (nature versus nurture) in the pathophysiolgical processes. Additionally, we focus on DNA methylation discussing the evidence for the role of that process in schizophrenia. Thirdly, we review the post-translational histone modifications and their role in schizophrenia. These investigations might surely lead further to the development of epigenetic therapy that looks promising in regard to symptom alleviation and the disease-associated cognitive deficit.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23101279     DOI: 10.2478/v10153-011-0082-x

Source DB:  PubMed          Journal:  Folia Med (Plovdiv)        ISSN: 0204-8043


  5 in total

1.  Nicotine restores Wt-like levels of reelin and GAD67 gene expression in brain of heterozygous reeler mice.

Authors:  Emilia Romano; Andrea Fuso; Giovanni Laviola
Journal:  Neurotox Res       Date:  2013-02-06       Impact factor: 3.911

2.  Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation.

Authors:  Rabia Nazik Yüksel; Neslihan Altunsoy; Baise Tikir; Merve Cingi Külük; Kubranur Unal; Sema Goka; Cigdem Aydemir; Erol Goka
Journal:  Ther Adv Psychopharmacol       Date:  2014-12

3.  Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysis.

Authors:  Johanna Hass; Esther Walton; Carrie Wright; Andreas Beyer; Markus Scholz; Jessica Turner; Jingyu Liu; Michael N Smolka; Veit Roessner; Scott R Sponheim; Randy L Gollub; Vince D Calhoun; Stefan Ehrlich
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-01-15       Impact factor: 5.067

Review 4.  MiRNAs of peripheral blood as the biomarker of schizophrenia.

Authors:  Kuanjun He; Chuang Guo; Lin He; Yongyong Shi
Journal:  Hereditas       Date:  2017-08-29       Impact factor: 3.271

Review 5.  Genetic and Epigenetic Etiology Underlying Autism Spectrum Disorder.

Authors:  Sang Hoon Yoon; Joonhyuk Choi; Won Ji Lee; Jeong Tae Do
Journal:  J Clin Med       Date:  2020-03-31       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.